KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Cash from Operations: 2009-2024

Historic Cash from Operations for Pacira BioSciences (PCRX) over the last 16 years, with Dec 2024 value amounting to $189.4 million.

  • Pacira BioSciences' Cash from Operations rose 12.82% to $60.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $141.4 million, marking a year-over-year decrease of 30.61%. This contributed to the annual value of $189.4 million for FY2024, which is 22.46% up from last year.
  • As of FY2024, Pacira BioSciences' Cash from Operations stood at $189.4 million, which was up 22.46% from $154.6 million recorded in FY2023.
  • In the past 5 years, Pacira BioSciences' Cash from Operations registered a high of $189.4 million during FY2024, and its lowest value of $77.0 million during FY2020.
  • For the 3-year period, Pacira BioSciences' Cash from Operations averaged around $163.1 million, with its median value being $154.6 million (2023).
  • Data for Pacira BioSciences' Cash from Operations shows a peak YoY spiked of 63.20% (in 2021) over the last 5 years.
  • Over the past 5 years, Pacira BioSciences' Cash from Operations (Yearly) stood at $77.0 million in 2020, then spiked by 63.20% to $125.7 million in 2021, then climbed by 15.56% to $145.3 million in 2022, then rose by 6.45% to $154.6 million in 2023, then grew by 22.46% to $189.4 million in 2024.